Beneficial influence of fungal metabolite nigerloxin on diabetes-induced oxidative stress in experimental rats

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 2, 2013, Pages 149-156

  Suresha, Bharathinagar S ^a   Vasantha, Kuntavalli Y ^a   Sattur, Avinash P ^a   Srinivasan, Krishnapura ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Antioxidant enzymes; Antioxidant molecules; Diabetes mellitus; Fungal metabolite; Lipid peroxides; Nigerloxin; Oxidative stress

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ASCORBIC ACID; GLUTATHIONE; LIPID PEROXIDE; NIGERLOXIN; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIVER FUNCTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ALDEHYDE REDUCTASE; ANIMALS; ASPERGILLUS NIGER; BENZOATES; DIABETES MELLITUS, EXPERIMENTAL; FERMENTATION; FREE RADICAL SCAVENGERS; LIPID PEROXIDES; LIVER; MALE; OXIDATIVE STRESS; PROPANE; RATS; RATS, WISTAR;

EID: 84874594841     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2012-0241     Document Type: Article

References (49)

1. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105: 121-126. doi:10.1016/S0076-6879(84)05016-3. PMID:6727660.
2. Babu, P.S., and Srinivasan, K. 1997. Hypolipidemic action of curcumin, coloring principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol. Cell. Biochem. 166: 169-175. doi:10.1023/A:1006819605211. PMID: 9046034.
3. Babu, P.S., and Srinivasan, K. 1998. Amelioration of renal lesions associated with diabetes by dietary curcumin in experimental rats. Mol. Cell. Biochem. 181: 87-96. doi:10.1023/A:1006821828706. PMID:9562245.
4. Beutler, E., Duron, O., and Kelly, B.M. 1963. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61: 882-888. PMID:13967893.
5. Brownlee, M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813-820. doi:10.1038/414813a. PMID:11742414.
6. Carlberg, I., and Mannervik, B. 1985. Glutathione reductase. Methods Enzymol. 113: 484-490. doi:10.1016/S0076-6879(85)13062-4. PMID:3003504.
7. Ceriello, A. 2003. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care, 26: 1589-1596. doi:10.2337/diacare.26.5.1589. PMID:12716823.
8. Chance, B., Greenstein, D.S., and Roughton, R.J.W. 1952. The mechanism of catalase action 1-steady state analysis. Arch. Biochem. Biophys. 37: 301-307. doi:10.1016/0003-9861(52)90194-X. PMID:14953443.
9. Chatterjee, S.N., Agarwal, S., Kumarjana, A., and Bose, B. 1988. Membrane lipid peroxidation and its pathological consequence. Indian J. Biochem. Biophys. 25: 25-31. PMID:3181980.
10. Evans, J.L., Goldfine, I.D., Maddux, B.A., and Grodsky, G.M. 2003. Are oxidative stress-activated signaling pathways mediators in insulin resistance and β-cell dysfunction? Diabetes, 52: 1-8. doi:10.2337/diabetes.52.1.1. PMID:12502486.
11. Fletcher, M.J. 1968. A colorimetric method for estimating serum triglycerides. Clin. Chim. Acta, 22: 303-307. doi:10.1016/0009-8981(68)90041-7. PMID: 5696963.
12. Flohe, L., and Gunzler, W.A. 1984. Assays of glutathione peroxidase. Methods Enzymol. 105: 114-121. doi:10.1016/S0076-6879(84)05015-1. PMID:6727659.
13. Flohe, L., and Otting, F. 1984. Superoxide dismutase assays. Methods Enzymol. 105: 93-104. doi:10.1016/S0076-6879(84)05013-8. PMID:6328209.
14. Folch, J., Lees, M., and Stanley, G.H.S. 1957. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 226: 497-509. PMID:13428781.
15. Halliwell, B., and Gutteridge, J.M.C. 1984. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet, 1: 1396-1397. doi:10.1016/S0140-6736(84)91886-5. PMID:6145845.
16. Halliwell, B, and Gutteridge, J.M.C. 1999. In Free radicals in biology and medicine. 3rd ed. Clarendon Press, Oxford, UK.
17. Hennig, B., and Chow, C.K. 1988. Lipid peroxidation and endothelial cell injury: Implications in atherosclerosis. Free Radic. Biol. Med. 4: 99-106. doi:10.1016/ 0891-5849(88)90070-6. PMID:3278952.
18. Hubel, C.A., Roberts, J.M., Taylor, R.N., Musci, T.J., Rodgers, G.M., and Me Laughlin, M.K. 1989. Lipid peroxidation in pregnancies: New perspectives on preeclampsia. Am. J. Obstet. Gynecol. 161: 1025-1034. doi:10.1016/0020-7292(90)90502-C. PMID:2679100.
19. Huggett, A.S.G., and Nixon, D.A. 1957. Use of glucose oxidase, peroxidase and o-dianisidine in the determination of blood and urinary glucose. Lancet, 273: 366-370. doi:10.1016/S0140-6736(57)92595-3. PMID:13464070.
20. Hunt, J.V., Dean, R.T., and Wolff, S.P. 1988. Hydroxyl radical production and autooxidative glycosylation. Biochem. J. 256: 205-212. PMID:2851978.
21. Jennings, P.B., Chirico, S., Jones, A.F., Lunec, J., and Barnett, A.H. 1987. Vitamin C metabolites and microangiopathy in diabetes mellitus. Diabetes Res. 6: 151-154. PMID:3436115.
22. Kakkar, R., Mantha, S.V., Radhi, J., Prasad, K., and Kalra, J. 1998. Increased oxidative stress in rat liver and pancreas during progression of streptozotocininduced diabetes. Clin. Sci. 94: 623-632. PMID:9854460.
23. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275. PMID: 14907713.
24. Maritim, A.C., Sanders, R.A., and Watkins, J.B. 2003. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17: 24-38. doi:10.1002/ jbt.10058. PMID:12616644.
25. Masella, R., Di Benedetto, R., Vari, R., Filesi, C., and Giovannini, C. 2005. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione related enzymes. J. Nutr. Biochem. 16: 577-586. doi:10.1016/j.jnutbio.2005.05.013. PMID:16111877.
26. McLennan, S.V., Heffernen, S., Wright, L., Rae, C., Fisher, E., Yue, D.K., and Turtle, J.R. 1991. Changes in hepatic glutathione metabolism in diabetes. Diabetes, 40: 344-348. doi:10.2337/diabetes.40.3.344. PMID:1671844.
27. Niskanen, L.K., Salonen, J.T., Nyssonen, K., and Uusitupa, M.I.J. 1995. Plasma lipid peroxidation and hyperglycemia: a connection through hyperinsulinaemia? Diabet. Med. 12: 802-808. PMID:8542741.
28. Ohkawa, H., Ohishi, N., and Yagi, K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358. doi:10. 1016/0003-2697(79)90738-3. PMID:36810.
29. Omaye, S.T., Turnbull, J.D., and Sauberlich, H.E. 1973. Selected methods for the determinations of the ascorbic acid in animal cells, tissues and fluids. Methods Enzymol. 62: 3-11. doi:10.1016/0076-6879(79)62181-X. 440112.
30. Palanduz, S., Ademoglu, E., Gokkusu, C., and Tamer, S. 2001. Plasma antioxidants and type 2 diabetes mellitus. Res. Commun. Mol. Pathol. Pharmacol. 109: 309-318. PMID:12889514.
31. Pushparaj, P., Tan, C.H., and Tan, B.K.H. 2000. Effects of Averrhoa bilimli leaf extract on blood glucose and lipids in streptozotocin diabetic rats. J. Ethnopharmacol. 72: 69-76. doi:10.1016/S0378-8741(00)00200-2. PMID:10967456.
32. Rajalingam, R., Srinivasan, N., and Govindarajulu, P. 1987. Effect of alloxaninduced diabetes on lipid profiles in renal cortex and medulla of mature albino rats. Indian J. Exp. Biol. 31: 577-579. PMID:8406610.
33. Rao, S.K.C., Divakar, S., Babu, N.K., Karanth, N.G., and Sattur, A.P. 2002. Nigerloxin, a novel inhibitor of aldose reductase and lipoxygenase with free radical scavenging activity from Aspergillus niger CFR-W-105. J. Antibiot. 55: 789-793. PMID:12458767.
34. Rao, S.K.C., Karanth, N.G., and Sattur, A.P. 2005. Production of nigerloxin, an enzyme inhibitor and a free radical scavenger, by Aspergillus niger using solid state fermentation. Process Biochem. 40: 2517-2522. doi:10.1016/j.procbio. 2004.10.008.
35. Robertson, R.P. 2004. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279: 42351-42354. doi:10.1074/jbc.R400019200. PMID:15258147.
36. Searcy, R.L., and Bergquist, L.M. 1960. A new colour reaction for the quantification of serum cholesterol. Clin. Chim. Acta, 5: 192-199. doi:10.1016/0009-8981(60)90035-8. PMID:14444356.
37. Sedlock, J., and Lindsay, R.H. 1968. Estimation of total, protein bound and nonprotein sulfhydryl groups in tissues with Ellman's reagent. Anal. Biochem. 25: 192-205. doi:10.1016/0003-2697(68)90092-4. PMID:4973948.
38. Sharma, S.R., Dwivedi, S.K., and Swarup, D. 1996. Hypoglycemic and hypolipidaemic effects of Cinnamomum tomalanees leaves. Indian J. Exp. Biol. 34: 372-374.
39. Sinclair, A.J. 1993. Free radical mechanisms and vascular complications of diabetes mellitus. Diabetes Rev. 2: 7-10.
40. Sochor, M., Baquer, N.Z., and McLean, P. 1979. Glucose overutilization in diabetes: evidence from studies on the changes in hexokinase, the pentose phosphate pathway and glucuronate-xylulose pathway in rat kidney cortex in diabetes. Biochem. Biophys. Res. Commun. 86: 32-39. doi:10.1016/0006-291X(79)90378-4. PMID:435303.
41. Stewart, J.C.M. 1980. Colorimetric estimation of phospholipids with ammonium ferrothio-cyanate. Anal. Biochem. 104: 10-14. doi:10.1016/0003-2697(80)90269-9. PMID:6892980.
42. Strain, J.J. 1991. Disturbances of micronutriment and antioxidant status in diabetes. Proc. Nutr. Soc. 50: 591-604. doi:10.1079/PNS19910073.
43. Sundaram, R.K., Bhaskar, A., Vijayalingam, S., Viswanathan, M., Mohan, R., and Shanmugasundaram, K.R. 1996. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin. Sci. 90: 255-260. PMID:8777831.
44. Suresha, B.S., Sattur, A.P., and Srinivasan, K. 2012. Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes. Can. J. Physiol. Pharmacol. 90: 387-394. doi:10.1139/y11-135. PMID:22423974.
45. Warholm, W., Guthenberg, C., Bahr, C.V., and Mannervik, B. 1985. Glutathione transferase from human liver. Methods Enzymol. 113: 499-504. doi:10.1016/ S0076-6879(85)13065-X. PMID:3003505.
46. Whitehead, H.W., Hawkes, N.D., Hainsworth, I., and Kingham, J.G.C. 1999. A prospective study of the causes of notably raised aspartate aminotrasferase of liver origin. Gut, 45: 129-133. doi:10.1136/gut.45.1.129. PMID:10369716.
47. Yagi, K. 1984. Assay for blood plasma or serum lipid peroxides. Methods Enzymol. 105: 328-331. PMID:6727672.
48. Yagi, K. 1987. Lipid peroxides and human diseases. Chem. Phys. Lipids, 45: 337-351. doi:10.1016/0009-3084(87)90071-5. PMID:3319232.
49. Young, I.S., Torney, J.J., and Trimble, E.R. 1992. The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Radic. Biol. Med. 13: 41-46. doi:10.1016/0891-5849(92)90164-C. PMID:1628852.